InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: Whalatane post# 9741

Tuesday, 07/02/2013 9:48:30 PM

Tuesday, July 02, 2013 9:48:30 PM

Post# of 426713
Akanz
In two years everyone, including the clinicians, will know the value of Vascepa. Right now, the focus is 30,000 high prescribers and of course smart share holders like yourself. EPA as a molecule in your blood, is "essential" to good health. Every diabetic should be taking "V" for regulating adiponectin levels.

I doubt any of the clinicians could remotely site the mechanism of action for EPA.

http://www.ncbi.nlm.nih.gov/pubmed/15655035

EPA and adiponectin:

http://www.ncbi.nlm.nih.gov/pubmed/17217160

The science is VERY strong, Amarin fruit is not ripe yet. High levels of plasma EPA will be the foundation to treating numerous chronic inflammatory diseases, this market dwarf's Anchor.

Williams




Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News